These results indicate that ARHGAP30 overexpression may ameliorate pancreatic cancer progression by inhibiting proliferation and metastasis and promoting apoptosis via regulation of the β-catenin pathway and related genes. This evidence concerns the gene ARHGAP30 and pancreatic neoplasm.